Leading Australian Research Institute Purchases HoloMonitor

A first HoloMonitor was recently deployed at QIMR Berghofer Medical Research Institute in Brisbane Australia. With the purchase, the institute upgrades its quantitative time-lapse cytometry capacity to also include instrumentation for measuring the behavior of individual cells in a cell population, without requiring the cells to be labeled with toxic chemicals or through genetic manipulation. The customer list price of the delivered HoloMonitor system amounts to €37 500.

HoloMonitor in operation at QIMR Berghofer

“Label-free cytometers based on conven­tional microscopy, marketed by Essen BioScience and others, are limited to measuring the bottom area covered by a cell population. This installation is special in that HoloMonitor expands and refines QIMR Berghofer’s current time-lapse capabilities to include label-free cell population analysis on an individual cell level — a new capability that medical science just has begun to explore”, said Peter Egelberg, CEO and founder of PHI.

QIMR Berghofer is home to more than 900* scientists, students and support staff. It is one of Australia’s most successful medical research institutes. The institute was established in 1945 by the Queensland Government and has a rich history of scientific discoveries and applied medical research.

*According to recent information provided by QIMR

The above information was made public pursuant to the EU Market Abuse Regulation.

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2